Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Scott Mason

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 11, 2008
Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjectsW Gordon Frankle, Raymond Y Cho, Rajesh Narendran, et al.
Synapse (New York, N.Y.)|December 8, 2017
An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxineW Gordon Frankle, Brigitte Robertson, Gary Maier, et al.
Synapse (New York, N.Y.)|March 2, 2011
Evaluation of dopamine D₂/₃ specific binding in the cerebellum for the positron emission tomography radiotracer [¹¹C]FLB 457: implications for measuring cortical dopamine releaseRajesh Narendran, N Scott Mason, Chi-Min Chen, et al.
Synapse (New York, N.Y.)|May 28, 2010
Positron emission tomography imaging of dopamine D₂/₃ receptors in the human cortex with [¹¹C]FLB 457: reproducibility studiesRajesh Narendran, N Scott Mason, Maureen A May, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2009
Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PETCharles M Laymon, N Scott Mason, W Gordon Frankle, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 28, 2010
A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatumRajesh Narendran, N Scott Mason, Charles M Laymon, et al.
Nuclear Medicine and Biology|May 31, 2020
Development of a PET radioligand selective for cerebral amyloid angiopathyEric E Abrahamson, Jeffrey S Stehouwer, Alberto L Vazquez, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 19, 2011
Age, sex, and reproductive hormone effects on brain serotonin-1A and serotonin-2A receptor binding in a healthy populationEydie L Moses-Kolko, Julie C Price, Nilesh Shah, et al.
Synapse (New York, N.Y.)|May 28, 2010
No effect of dopamine depletion on the binding of the high-affinity D 2/3 radiotracer [11C]FLB 457 in the human cortexW Gordon Frankle, N Scott Mason, Eugenii A Rabiner, et al.
Synapse (New York, N.Y.)|March 21, 2009
Positron emission tomography imaging of D(2/3) agonist binding in healthy human subjects with the radiotracer [(11)C]-N-propyl-norapomorphine: preliminary evaluation and reproducibility studiesRajesh Narendran, W Gordon Frankle, N Scott Mason, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 11, 2008
Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjectsW Gordon Frankle, Raymond Y Cho, Rajesh Narendran, et al.
Synapse (New York, N.Y.)|December 8, 2017
An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxineW Gordon Frankle, Brigitte Robertson, Gary Maier, et al.
Synapse (New York, N.Y.)|March 2, 2011
Evaluation of dopamine D₂/₃ specific binding in the cerebellum for the positron emission tomography radiotracer [¹¹C]FLB 457: implications for measuring cortical dopamine releaseRajesh Narendran, N Scott Mason, Chi-Min Chen, et al.
Synapse (New York, N.Y.)|May 28, 2010
Positron emission tomography imaging of dopamine D₂/₃ receptors in the human cortex with [¹¹C]FLB 457: reproducibility studiesRajesh Narendran, N Scott Mason, Maureen A May, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2009
Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PETCharles M Laymon, N Scott Mason, W Gordon Frankle, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 28, 2010
A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatumRajesh Narendran, N Scott Mason, Charles M Laymon, et al.
Nuclear Medicine and Biology|May 31, 2020
Development of a PET radioligand selective for cerebral amyloid angiopathyEric E Abrahamson, Jeffrey S Stehouwer, Alberto L Vazquez, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 19, 2011
Age, sex, and reproductive hormone effects on brain serotonin-1A and serotonin-2A receptor binding in a healthy populationEydie L Moses-Kolko, Julie C Price, Nilesh Shah, et al.
Synapse (New York, N.Y.)|May 28, 2010
No effect of dopamine depletion on the binding of the high-affinity D 2/3 radiotracer [11C]FLB 457 in the human cortexW Gordon Frankle, N Scott Mason, Eugenii A Rabiner, et al.
Synapse (New York, N.Y.)|March 21, 2009
Positron emission tomography imaging of D(2/3) agonist binding in healthy human subjects with the radiotracer [(11)C]-N-propyl-norapomorphine: preliminary evaluation and reproducibility studiesRajesh Narendran, W Gordon Frankle, N Scott Mason, et al.
Pageof 5